| Pharmaceutical Information |
| Drug Name |
Semaxanib |
| Drug ID |
BADD_D02007 |
| Description |
Not Available |
| Indications and Usage |
Investigated for use/treatment in colorectal cancer and lung cancer. |
| Marketing Status |
Not Available |
| ATC Code |
Not Available |
| DrugBank ID |
DB06436
|
| KEGG ID |
D05819
|
| MeSH ID |
C116890
|
| PubChem ID |
5329098
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| Synonyms |
Semaxinib | SU 5416 | SU5416 | Sugen 5416 | SU-5416 | 3-(2,4-dimethylpyrrol-5-yl)methylidene-indolin-2-one |
|
| Chemical Information |
| Molecular Formula |
C15H14N2O |
| CAS Registry Number |
194413-58-6 |
| SMILES |
CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
